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S D SHORVON, E H REYNOLDS Abstract
In 94 previously untreated new referrals to a neurological clinic with tonic-clonic or partial seizures or both the failure rate for optimum single-drug treatment with phenytoin or carbamazepine after a median of 32 months was 17%. Failure of single-drug treatment was associated especially with the presence of additional neuropsychiatric handicaps but also with partial or mixed seizures, symptomatic epilepsy, and a higher number and frequency of tonic-clonic or partial seizures before treatment. Analysis of the recurrence of seizures suggested that the first year of treatment may be crucial in determining the long-term prognosis.
These findings are in keeping with the concept that seizures may predispose to further seizures, and imply that early, effective treatment may be important to prevent evolution into chronic and more intractable epilepsy.
Introduction
Epilepsy is usually a chronic disorder with a widely varying outcome. ' Rodin' in his detailed review commented that most reports were retrospective surveys of selected groups of patients with chronic epilepsy who had gravitated to institutions or hospital clinics, often with inadequate documentation and follow-up.
In the past six years we have undertaken studies of single-drug treatment with either phenytoin or carbamazepine, in which we have monitored drug concentrations, in new referrals to a neurological clinic with previously untreated tonic-clonic or partial seizures, or both. In addition to the pharmacological aspects already reported4-7 this has given us the opportunity of studying for the first time, prospectively and from the onset of epilepsy, factors that influence the prognosis for control of seizures.
Patients and methods
We studied 106 consecutive referrals to a neurological clinic with tonic-clonic or partial epilepsy, or both, who had not been treated previously, had no progressive cerebral disorder, and Four patients were withdrawn (two with tumours and two with skin reactions to carbamazepine); eight were lost to follow-up (after a median of 24 months, range 13-33 months); and 94 (890,, of the total) were followed up for a median of 32 months (range 12-70 months). The frequency of clinic visits varied from two-weekly to six-monthly (mean once every 3 4 months). Table I summarises the clinical details of the initial 106 patients and of the 94 patients on whom the data analysis was based. Symptomatic epilepsy was defined as tonicclonic or partial seizures, or both, associated with a clear history or evidence on examination of a cerebral lesion (for example, perinatal trauma, hemiparesis). A neuropsychiatric handicap was defined as evidence of a cerebral lesion, mental retardation, or psychological or social difficulties of a degree sufficient for referral to a psychiatrist or a social worker. 
Results
To analyse factors influencing control of seizures we combined the data obtained in the two drug groups since our own and other studies have failed to show any important differences in the anticonvulsant efficacy of phenytoin and carbamazepine either in new referrals5 6 or in patients with chronic epilepsy.8 9 Patients were classified into five groups on the basis of overall control of seizures according to criteria defined previously (table II).4 5 Monotherapy was successful in 72 patients (groups 1-3) and failed in 16 (group 5). Six patients (group 4) continued to have seizures without achieving optimum drug concentrations, probably due to poor compliance. Of the eight patients lost to follow-up, four were in group 1, two in group 4, and two in group 5 when last seen. 
Discussion
These findings in 94 patients followed up for a median of 32 months confirm our earlier observations4 5 in smaller numbers followed up for shorter periods and suggest that in new, previously untreated referrals to a neurological clinic the prognosis for control of tonic-clonic or partial seizures, or both, with phenytoin or carbamazepine is fairly good. Complete control was achieved in 72 patients, the failure rate for optimum single-drug treatment was 17 U) and in a further 6",, of patients seizures remained uncontrolled and were associated with low blood drug concentrations, probably due to poor compliance.
In this report we were mainly concerned to examine the clinical features associated with a successful or unsuccessful response to single-drug treatment. The niost striking association with failure of treatment was the presence of an additional neurological or psychosocial handicap. The mechanism of this effect may be partly mediated by the influence of cerebral lesions as there was also an association between poor control, partial or mixed seizures, and symptomatic epilepsy. Thus in patients with combined partial or mixed seizures, symptomatic epilepsy, and additional neuropsychiatric handicaps the failure rate for optimum single-drug treatment rose to 35 . These observations are in accord with the finding by Rodin' in patients with chronic epilepsy of an adverse influence of psychomotor or mixed seizure types, an abnormal neurological or mental state on examination, or a low IQ. A further interesting observation is that failure of monotherapy was associated with a greater number and frequency of both tonic-clonic and partial seizures before treatment. This also agrees with Rodin's conclusions' that the longer the history of epilepsy and the more seizures experienced the less likely will be complete seizure control. Other factors that so far we have not found to exert any appreciable influence on outcome are age, sex, age at onset of epilepsy, perinatal, childhood, or family history, and electroencephalographic findings.
We also examined in detail the recurrence of seizures during carefully monitored anticonvulsant treatment. The remarkable finding was that in patients followed up for three years most (85" ) of the relapses occurred in the first year, with only 150 of patients relapsing for the first time during the second and third years of treatment (figure). Furthermore, patients who had a seizure within the first year had a significantly higher chance of having seizures in future years compared with patients in whom the first year was seizure free. Probably many factors determine the prognosis for control of seizures from the onset of treatment, including those we have studied and possibly others. One possibility is that during the first year of treatment more "severe" cases of epilepsy are sorted out from milder forms of the disorder. Another possibility, however, was suggested by Gowers"' in 1881 when he noted that "the effect of a convulsion on the nerve centres is such as to render the occurrence of another more easy, to intensify the predisposition that already exists. Thus every fit may be said to be, in part, the result of those which have preceded it, the cause of those which follow it." The implication of Gowers' s concept is that the more seizures that have occurred the more difficult they may be to control, and that the earlier seizures are suppressed the better the prognosis. Some of our observations lend support to Gowers's view : the greater the number and frequency of seizures before treatment the worse the prognosis; the prognosis for control of seizures in new referrals is fairly good compared with our own and common experience' that chronic seizures are more difficult to control; and good control during the first year of treatment implies a better prognosis than if seizures recur in this period.
Retrospective community surveys2 show a rather better longterm prognosis for remission of seizures than hospital-based studies,' although the former have also confirmed that the longer seizures have continued the lower the remission rate. The differences in outcome between community-and hospital-based studies may be due to the inclusion of all cases from the inception of epilepsy in community studies and the tendency for more resistant cases of chronic epilepsy to be treated in hospital clinics. The present study is the first to attempt to evaluate prospectively the factors influencing prognosis from the onset of epilepsy in a hospital setting. To what extent the patients in this study are representative of patients in the community is uncertain, but further long-term investigations of this kind, including children, may resolve the discrepancies between hospital-and communitybased surveys. There is also clearly a need for more investigation into the early years of treatment of epilepsy, which has been surprisingly neglected.7
I" The present evidence suggests that patients with a poorer prognosis may be identified fairly early in the course of treatment. The first year may be crucial in determining the future course and prognosis of what is often a chronic and sometimes a lifelong disorder.
(Accepted 14 September 1982) QUACKS AND QUACK REMEDIES I have considered this matter as far as lies in my power; and I do not think it possible that any Act of Parliament can prevent a man from acting as a quack ... if the College of Surgeons were to endeavour to bring such a Bill into the House of Commons, we should be beat, head over heels, upon that very point, of preventing people from practising who wish to practise for the public advantage. We should have gentlemen rising up on all sides saying, "I was cured by Mr St John Long: I was cured by Morrison's pills, when the regular doctors could not do it." I know therefore that any such attempts on our part would utterly fail . . . I have no objection to a man selling, if he pleases, quack medicines. In the first place, I know people will have them. It is like brandy, and French gloves and other things. It will only become a surreptitious trade if you do not permit it; but I would have a tax put on such things.-GEORGE JAMES GUTHRIE, PRCS. (Select Committee on Medical Education. Parliamentary Papers 1834.)
MEDICINES APPROPRIATED TO THE TEETH-Vehement heat, and vehement cold, are inimical to the teeth, but they are most of all offended by sharp and sour things, and the reason is, because they have neither skin nor flesh to cover them, they delight in such medicines as are cleansing and binding, because they are troubled with defluxions and rheums upon every light occasion; and that's the reason the common use of fat and sweet things, soon rots the teeth. (Nicholas Culpeper (1616-54) The Complete Herbal, 1850.)
